M-TERIFLUNOMIDE

mantra pharma inc🇨🇦 Health Canada

Approval Id: f9adc506f3165b79
Drug Approval Canada Name: M-TERIFLUNOMIDE
Product Name: M-TERIFLUNOMIDE
Status: Marketed
Status Date: 2022-05-16
Original Market Date: 2022-05-16
Din: 02523833
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 90:04.20
Atc Original: L04AK02 TERIFLUNOMIDE
Atc Name: l 04 ak 02
Aig Number: 0154970001
Company Name: mantra pharma inc
Company Address: 1000 Rue Du Lux Suite 201, Brossard, Quebec, Canada, J4Y 0E3

TERIFLUNOMIDE

14 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

f9adc506f3165b79

Type

Standard